Becton, Dickinson and Company's SWOT analysis: med tech stock poised for growth
Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...
BD And Biosero Partner To Integrate Robotics With Flow Cytometry
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
NYSE:BDX) BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and ...
Assembly Mag4d
Becton Dickinson Boosts U.S. Manufacturing of Critical Medical Devices
Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...
Becton Dickinson EVP Michael David Garrison sells $141,196 in stock
Michael David Garrison, Executive Vice President and President of Medical (TASE:PMCN) at Becton Dickinson & Co. (NYSE:BDX), recently sold 597 shares of the company’s common stock. The shares were sold ...
Becton, Dickinson: Hold, Momentum Is Gaining, Just Need More Growth
Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...